{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,7,31]],"date-time":"2024-07-31T19:53:48Z","timestamp":1722455628616},"reference-count":37,"publisher":"Springer Science and Business Media LLC","issue":"9","license":[{"start":{"date-parts":[[2006,9,1]],"date-time":"2006-09-01T00:00:00Z","timestamp":1157068800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Nervenarzt"],"published-print":{"date-parts":[[2006,9]]},"DOI":"10.1007\/s00115-006-2087-x","type":"journal-article","created":{"date-parts":[[2006,5,18]],"date-time":"2006-05-18T16:15:11Z","timestamp":1147968911000},"page":"1123-1132","source":"Crossref","is-referenced-by-count":6,"title":["Soziale Angstst\u00f6rungen","Social anxiety disorders"],"prefix":"10.1007","volume":"77","author":[{"given":"B.","family":"Renneberg","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.","family":"Str\u00f6hle","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"2087_CR1","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1521\/pedi.16.1.1.22558","volume":"16","author":"Alden","year":"2002","unstructured":"Alden LE, Laposa JM, Taylor CT et al. (2002) Avoidant personality disorder: current status and future directions. J Personal Disord 16: 1\u201329","journal-title":"J Personal Disord"},{"key":"2087_CR2","doi-asserted-by":"crossref","unstructured":"Bennett-Levy J, Butler G, Fennell M et al. (2004) Oxford Guide to behavioural experiments in cognitive therapy. Oxford University Press, Oxford","DOI":"10.1093\/med:psych\/9780198529163.001.0001"},{"key":"2087_CR3","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1002\/da.10096","volume":"18","author":"Blanco","year":"2003","unstructured":"Blanco C, Schneier FR, Schmidt A (2003) Pharmacological treatment of social anxiety disorder: a meta analysis. Depress Anxiety 18: 29\u201340","journal-title":"Depress Anxiety"},{"key":"2087_CR4","unstructured":"Bronisch T, Hiller W, Zaudig M et al. (1995) IDCL-P\u2014Internationale Diagnosen Checklisten f\u00fcr Pers\u00f6nlichkeitsst\u00f6rungen nach ICD-10 und DSM-IV (Manual). Huber, Bern"},{"key":"2087_CR5","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1097\/00004714-199312000-00008","volume":"13","author":"Davidson","year":"1993","unstructured":"Davidson J, Potts NER (1993) Treatment of social phobia with clonazepam and placebo. J Clin Psychopharmacol 13: 423\u2013428","journal-title":"J Clin Psychopharmacol"},{"key":"2087_CR6","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1002\/1520-6394(2000)12:2<111::AID-DA9>3.0.CO;2-3","volume":"12","author":"Emmanuel","year":"2000","unstructured":"Emmanuel N, Brawman-Mintzer O, Morton W (2000) Buproprion-SR in the treatment of social phobia. Depress Anxiety 12: 111\u2013113","journal-title":"Depress Anxiety"},{"key":"2087_CR7","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1097\/00004714-200106000-00011","volume":"21","author":"Federoff","year":"2001","unstructured":"Federoff I, Taylor S (2001) Psychological and pharmacological treatments of social phobia: a meta analysis. J Clin Psychopharmacol 21: 311\u2013324","journal-title":"J Clin Psychopharmacol"},{"key":"2087_CR8","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1521\/pedi.1996.10.2.174","volume":"10","author":"Feske","year":"1996","unstructured":"Feske U, Perry KJ, Chambless DL et al. (1996) Avoidant personality disorder as a predictor for treatment outcome among generalized social phobics. J Personal Disord 10: 174\u2013184","journal-title":"J Personal Disord"},{"key":"2087_CR9","unstructured":"Fydrich T, Renneberg B, Schmitz B et al. (1997) Strukturiertes Klinisches Interview f\u00fcr DSM-IV, Achse II: Pers\u00f6nlichkeitsst\u00f6rungen \u2013 SKID-II. Hogrefe, G\u00f6ttingen"},{"key":"2087_CR10","doi-asserted-by":"crossref","first-page":"938","DOI":"10.1001\/archpsyc.1991.01810340070009","volume":"48","author":"Gelernter","year":"1991","unstructured":"Gelernter C, Uhde T, Cimbolic P (1991) Cognitive-behavioral and pharmacological treatments of social phobia. A controlled study. Arch Gen Psychiatry 48: 938\u2013945","journal-title":"Arch Gen Psychiatry"},{"key":"2087_CR11","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1111\/j.1468-2850.1997.tb00123.x","volume":"4","author":"Gould","year":"1997","unstructured":"Gould R, Buckminster S, Pollack M et al. (1997) Cognitive-behavioral and pharmacological treatment for social phobia: a meta analysis. Clin Psychol Sci Pract 4: 291\u2013306","journal-title":"Clin Psychol Sci Pract"},{"key":"2087_CR12","first-page":"Von","volume":"Wandel","author":"Grawe","year":"1994","unstructured":"Grawe K (1994) Psychotherapie im Wandel: Von der Konfession zur Profession. Hogrefe, G\u00f6ttingen","journal-title":"Psychotherapie im"},{"key":"2087_CR13","doi-asserted-by":"crossref","first-page":"1133","DOI":"10.1001\/archpsyc.55.12.1133","volume":"55","author":"Heimberg","year":"1998","unstructured":"Heimberg R, Liebowitz M, Hope D (1998) Cognitive-behavioral group therapy versus phenelzine in social phobia: 12-week outcome. Arch Gen Psychiatry 55: 1133\u20131141","journal-title":"Arch Gen Psychiatry"},{"key":"2087_CR14","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1192\/bjp.186.3.222","volume":"186","author":"Kasper","year":"2005","unstructured":"Kasper S, Stein D, Loft H et al. (2005) Escitalopram in the treatment of social anxiety disorder: randomized, placebo-controlled, flexible dosage study. Br J Psychiatry 186: 222\u2013226","journal-title":"Br J Psychiatry"},{"key":"2087_CR15","unstructured":"Lieb R, M\u00fcller N (2002) Epidemiologie und Komorbidit\u00e4t der Sozialen Phobie. In: Stangier U, Fydrich T (Hrsg) Soziale Phobie und Soziale Angstst\u00f6rung. Hogrefe, G\u00f6ttingen, S\u00a034\u201365"},{"key":"2087_CR16","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1001\/archpsyc.62.2.190","volume":"62","author":"Liebowitz","year":"2005","unstructured":"Liebowitz M, Gelenberg A, Munjack D (2005) Venlafaxine extended release vs placebo and paroxetine in social anxiety disorder. Arch Gen Psychiatry 62: 190\u2013198","journal-title":"Arch Gen Psychiatry"},{"key":"2087_CR17","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1001\/archpsyc.49.4.290","volume":"49","author":"Liebowitz","year":"1992","unstructured":"Liebowitz M, Schneier F, Campeas R (1992) Phenelzine versus atenolol in social phobia. A placebo controlled comparison. Arch Gen Psychiatry 49: 290\u2013300","journal-title":"Arch Gen Psychiatry"},{"key":"2087_CR18","doi-asserted-by":"crossref","first-page":"1814","DOI":"10.1176\/ajp.156.11.1814","volume":"156","author":"Lipsitz","year":"1999","unstructured":"Lipsitz JD, Markowitz JC, Cherry S et al. (1999) Open trial of interpersonal psychotherapy for the treatment of social phobia. Am J Psychiatry 156: 1814\u20131816","journal-title":"Am J Psychiatry"},{"key":"2087_CR19","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1001\/archpsyc.1996.01830020077009","volume":"53","author":"Magee","year":"1996","unstructured":"Magee WJ, Eaton WW, Wittchen H-U et al. (1996) Agoraphobia, simple phobia, and social phobia in the National Comorbidity Survey. Arch Gen Psychiatry 53: 159\u2013168","journal-title":"Arch Gen Psychiatry"},{"key":"2087_CR20","unstructured":"Mombour W, Zaudig M, Berger P (1996) International Personality Disorder Examination (IPDE). ICD-10 Modul -Deutschsprachige Ausgabe. Huber, Bern"},{"key":"2087_CR21","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1097\/00004714-199908000-00010","volume":"19","author":"Pande","year":"1999","unstructured":"Pande A, Davidson J, Jefferson J et al. (1999) Treatment of social phobia with gabapentin: a placebo-controlled study. J Clin Psychopharmacol 19: 341\u2013348","journal-title":"J Clin Psychopharmacol"},{"key":"2087_CR22","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1097\/01.jcp.0000117423.05703.e7","volume":"24","author":"Pande","year":"2004","unstructured":"Pande A, Feltner D, Jefferson J (2004) Efficacy of the novel anxiolytic pregabalin in social anxiety disorder: a placebo-controlled, multicenter study. J Clin Psychopharmacol 24: 141\u2013149","journal-title":"J Clin Psychopharmacol"},{"key":"2087_CR23","unstructured":"Renneberg B, Fydrich T (1999) Verhaltenstherapeutische Therapiekonzepte in der Gruppenbehandlung der selbstunsicheren Pers\u00f6nlichkeitsst\u00f6rung. In: Sa\u00df H, Herpetz S (Hrsg) Psychotherapie von Pers\u00f6nlichkeitsst\u00f6rungen. Thieme, Stuttgart, S\u00a0159\u2013170"},{"key":"2087_CR24","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1016\/S0005-7894(05)80337-5","volume":"21","author":"Renneberg","year":"1990","unstructured":"Renneberg B, Goldstein AJ, Phillips D et al. (1990) Intensive behavioral group treatment for avoidant personality disorder. Behav Ther 21: 363\u2013377","journal-title":"Behav Ther"},{"key":"2087_CR25","doi-asserted-by":"crossref","first-page":"883","DOI":"10.1016\/j.cpr.2004.07.007","volume":"24","author":"Rodebaugh","year":"2004","unstructured":"Rodebaugh TL, Holaway RM, Heimberg RG (2004) The treatment of social anxiety disorder. Clin Psychol Rev 24: 883\u2013908","journal-title":"Clin Psychol Rev"},{"key":"2087_CR26","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1002\/(SICI)1520-6394(1998)7:3<126::AID-DA5>3.0.CO;2-9","volume":"7","author":"Simpson","year":"1998","unstructured":"Simpson H, Schneier F, Marshall R (1998) Low-dose selegiline (LDeprenyl) in social phobia. Depress Anxiety 7: 126\u2013129","journal-title":"Depress Anxiety"},{"key":"2087_CR27","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1026\/\/0084-5345.28.1.28","volume":"28","author":"Stangier","year":"1999","unstructured":"Stangier U, Heidenreich T, Berardi A et al. (1999) Die Erfassung sozialer Phobie durch die Social Interaction Anxiety Scale (SIAS) und die Social Phobia Scale (SPS). Z Klin Psychol 28: 28\u201336","journal-title":"Z Klin Psychol"},{"key":"2087_CR28","unstructured":"Stangier U, Heidenreich T, Peitz M (2003) Soziale Phobien. Ein kognitiv-verhaltenstherapeutisches Behandlungsmanual. Beltz PVU, Weinheim"},{"key":"2087_CR29","doi-asserted-by":"crossref","first-page":"708","DOI":"10.1001\/jama.280.8.708","volume":"280","author":"Stein","year":"1998","unstructured":"Stein M, Liebowitz M, Lydiard R (1998) Paroxetine treatment of generalized social phobia (social anxiety disorder): a randomized, controlled trial. JAMA 280: 708\u2013713","journal-title":"JAMA"},{"key":"2087_CR30","doi-asserted-by":"crossref","unstructured":"Str\u00f6hle A (2005) New pharmacological treatment approaches for anxiety disorders. In: Holsboer F, Str\u00f6hle A (eds) Handbook of experimental pharmacology: anxiety and anxiolytic drugs. Springer, Berlin Heidelberg New York, pp\u00a0505\u2013526","DOI":"10.1007\/3-540-28082-0_18"},{"key":"2087_CR31","doi-asserted-by":"crossref","first-page":"590","DOI":"10.1001\/archpsyc.58.6.590","volume":"58","author":"Torgersen","year":"2001","unstructured":"Torgersen S, Kringlen E, Cramer V (2001) The prevalence of personality disorders in a community sample. Arch Gen Psychiatry 58: 590\u2013596","journal-title":"Arch Gen Psychiatry"},{"key":"2087_CR32","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1037\/0022-006X.62.2.350","volume":"62","author":"Turner","year":"1994","unstructured":"Turner S, Beidel D, Jacob R (1994) Social phobia: a comparison of behavior therapy and atenolol. J Consult Clin Psychol 62: 350\u2013358","journal-title":"J Consult Clin Psychol"},{"key":"2087_CR33","doi-asserted-by":"crossref","first-page":"1007","DOI":"10.1037\/0022-3514.79.6.1007","volume":"79","author":"Twenge","year":"2000","unstructured":"Twenge JM (2000) The age of anxiety? Birth cohort change in anxiety and neuroticism, 1952\u20131993. J Pers Soc Psychol 79: 1007\u20131021","journal-title":"J Pers Soc Psychol"},{"key":"2087_CR34","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1017\/S1092852900006933","volume":"8","author":"Van Ameringen","year":"2003","unstructured":"Van Ameringen M, Allgulander C, Bandelow B (2003) WCA recommendations for the long term treatment of social phobia. CNS Spectr 8: 40\u201352","journal-title":"CNS Spectr"},{"key":"2087_CR35","first-page":"an","volume":"phobia","author":"Van","year":"2000","unstructured":"Van Vliet I, van Veen J, Westenberg H (2000) Mirtazapine in social phobia: an open pilot study. Programs and Abstracts of the Collegum Internationale Neuropsychopharmacolgicum (CINP), Brussels","journal-title":"Mirtazapine in social"},{"key":"2087_CR36","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1097\/00004714-198808000-00008","volume":"8","author":"Versiani","year":"1988","unstructured":"Versiani M, Mundim F, Nardi A et al. (1988) Tranylcypromine in social phobia. J Clin Psychopharmacol 8: 279\u2013283","journal-title":"J Clin Psychopharmacol"},{"key":"2087_CR37","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1026\/0084-5345.33.1.42","volume":"33","author":"Willutzki","year":"2004","unstructured":"Willutzki U, Neumann B, Haas H et al. (2004) Zur Psychotherapie sozialer \u00c4ngste: Kognitive Verhaltenstherapie im Vergleich zu einem kombiniert ressourcenorientierten Vorgehen. Eine randomisierte kontrollierte Interventionsstudie. Z Klin Psychol Psychother 33: 42\u201350","journal-title":"Z Klin Psychol Psychother"}],"container-title":["Der Nervenarzt"],"original-title":[],"language":"de","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00115-006-2087-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00115-006-2087-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00115-006-2087-x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,7]],"date-time":"2023-05-07T13:01:24Z","timestamp":1683464484000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00115-006-2087-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2006,9]]},"references-count":37,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2006,9]]}},"alternative-id":["2087"],"URL":"https:\/\/doi.org\/10.1007\/s00115-006-2087-x","relation":{},"ISSN":["0028-2804","1433-0407"],"issn-type":[{"value":"0028-2804","type":"print"},{"value":"1433-0407","type":"electronic"}],"subject":[],"published":{"date-parts":[[2006,9]]}}}